logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Peter L. Anderson

university of new mexico
H指数:64
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Application of an Intracellular LC-MS/MS Assay for the Determination of Carbovir-Triphosphate and Remdesivir-Triphosphate in Peripheral Blood Mononuclear Cells and Dried Blood Spots

应用细胞内LC-MS/MS分析方法测定外周血单核细胞和干血斑中的卡博韦三磷酸和瑞德西韦三磷酸

Journal of Pharmaceutical and Biomedical Analysis
IF3.1
2026-09-170
OAAI
Stefanie K. Schwab; Laura E. Roon; Lane R. Bushman; Ryan P. Coyle; Bethany M. Johnson; Lucas A. Ellison; Peter L. Anderson; Kristina M. Brooks
A Narrative Review of Remote Biospecimen Collection Product and Implementation Considerations for Sexual Health Clinical Research

远程生物样本采集产品及其在性健康临床研究中的应用考量综述

AIDS and Behavior
IF2.4
2026-05-260
OAAI
Keith J. Horvath; Sarah E. Rutstein; Ryan P. Coyle; Cheryl Jennings; Rahim Z. Miller; Justin Unternaher; Kelly Bojan; Grace M. Aldrovandi; K. Rivet Amico; Peter L. Anderson; Nadia Dowshen; Sybil Hosek; Lisa Hightow-Weidman; Mark A. Marzinke
Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial

对使用兴奋剂的男性实施积极心理干预以降低HIV感染风险：一项随机对照试验方案

BMJ Open
IF2.3
2026-05-110
PRE
Valentin, Omar R.; Henderson, Chelsea; Coffin, Lara S.; Paredes-Gotamco, Julian; Olem, David; Farrales, Willi; Neilands, Torsten B.; Dilworth, Samantha E.; Doblecki-Lewis, Susanne; Page, Kimberly; Moskowitz, Judith T.; Anderson, Peter L.; Johnson, Mallory O.; Carrico, Adam W.
The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis

利福平对HIV相关结核病患者中替诺福韦艾拉酚胺富马酸酯血浆及细胞内药代动力学的影响

JAIDS-Journal of Acquired Immune Deficiency Syndromes
IF2.2
2026-04-010
PRE
Mpofu, Rephaim; Chandiwana, Nomathemba; Sokhela, Simiso; Moorhouse, Michelle; Venter, Francois; Anderson, Peter L.; Wiesner, Lubbe; Boffito, Marta; Maartens, Gary; Sinxadi, Phumla
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum

开发一种半机制性群体药代动力学模型，用于预测妊娠期和产后期坦诺福韦二吡呋酯和坦诺福韦艾拉夫amide在血浆和细胞基质中的暴露情况

Clinical Pharmacokinetics
IF4
2025-11-120
OAAI
Yifan Yu; Kristina M. Brooks; Gustavo F. Doncel; Brookie M. Best; Mark A. Marzinke; Mark Mirochnick; Peter Anderson; Landon Myer; Connie Celum; Renee Heffron; Jenell Coleman; Dvora Joseph Davey; Craig W. Hendrix; Jeremiah D. Momper; Robert Bies; Rachel K. Scott
Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study

在妊娠期间使用dapivirine阴道环或口服PrEP的婴儿的安全结局（MTN-042/DELIVER）：一项随机3b期研究

The Lancet HIV
IF0
2025-10-290
PRE
Lee Fairlie; Daniel W Szydlo; Ashley Mayo; Katie Bunge; Felix Mhlanga; Jeanna Piper; Sufia Dadabhai; Vanessa M Gatsi; Elizea Horne; Phionah Kibalama Ssemambo; Vitumbiko Mandiwa; Nyaradzo M Mgodi; Maxensia Owor; Peter L Anderson; Mark A Marzinke; Clemensia Nakabiito; Rachel Scheckter; Catherine Chappell; Sharon L Hillier
Investigating the HIV epidemic among Black gay and bisexual men in the Southern United States: Results of the HPTN 096 pilot cross-sectional assessment

调查美国南部黑人男男同性恋和双性恋人群中的艾滋病流行情况：HPTN 096试点横断面评估的结果

PLOS ONE
IF2.6
2025-10-170
PRE
Beyrer, Chris; Remien, Robert H.; Eshleman, Susan H.; Gamble, Theresa R.; De Dieu Tapsoba, Jean; Labbett, Rita L.; Sullivan, Philip A.; Laeyendecker, Oliver; Anderson, Peter L.; Agravat, Devang; Hughes, James P.; Driffin, Daniel D.; Hutchinson, Craig S.; Hucks-Ortiz, Christopher; Adair, Maurice; Curry, Melissa; Jones, Shakita Brooks; Haddock, Ian L.; Boyd, Donte; Burwen, Dale R.; Johnson, Anna Satcher; Nelson, LaRon E.
In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort

在《不匹配：多中心艾滋病队列研究/女性机构HIV研究联合队列中，尽管干血斑中替诺福韦二磷酸盐水平低，病毒仍被抑制》

CLINICAL INFECTIOUS DISEASES
IF7.3
2025-10-010
PRE
Mann, Sarah C.; Lykins, David; Coyle, Ryan P.; Witt, Mallory D.; Kim, Eun-Young; Macatangay, Bernard; Brown, Todd T.; Dionne, Jodie A.; Alcaide, Maria; Lahiri, Cecile Delille; Ramirez, Catalina; Dumond, Julie B.; D'Souza, Gypsyamber; Cohen, Mardge H.; Wilson, Tracey E.; Kassaye, Seble; Tien, Phyllis C.; Adedimeji, Adebola A.; Ellison, Lucas; Brooks, Kristina M.; Bushman, Lane R.; Anderson, Peter L.; MaWhinney, Samantha
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa

一项横断面研究，评估在肯尼亚、津巴布韦、斯威士兰和南非开展的替诺福韦二吡呋酯为基础的暴露前预防项目中，被诊断为HIV-1感染者中HIV耐药突变的发生频率。

Journal of the International AIDS Society
IF4.9
2025-08-200
OA
Urvi M. Parikh; Lauren D. Kudrick; Lisa Levy; Everline Bosek; Bhavna H. Chohan; Irene Mukui; Sarah Masyuko; Nonhlanhla Ndlovu; Imelda Mahaka; Owen Mugurungi; Gertrude Ncube; Anita Hettema; Sindy N. Matse; Saiqa Mullick; Carole L. Wallis; Amy L. Heaps; Kerri J. Penrose; Kevin D. McCormick; Lubbe Wiesner; Peter L. Anderson; Jill M. Peterson; Connie Celum; Barbra A. Richardson; Delivette Castor; Shannon Allen; Kristine Torjesen; John W. Mellors; Global Evaluation of Microbicide Sensitivity (GEMS) Project
Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV

替诺福韦二磷酸在干血斑中的浓度可预测青少年HIV患者的未来病毒抑制情况，但不能预测病毒学失败。

AIDS
IF3.1
2025-07-310
PRE
Antwi, Sampsona, b; Yang, Hongmeic; Enimil, Anthonya, b; Martyn-Dickens, Charlesb; Dompreh, Albertd, e; Sly-Moore, Eugeniab; Bosomtwe, Dennisb; Amissah, Aikins Kofib; Ojewale, Oluwayemisif; Asiedu, Priscillab; Appiah, Augustina Frimpongb; Opoku, Theresahb; Sarfo, Ama D.b; Kusi-Amponsah, Isaacd; Bushman, Lane R.g; Ellison, Lucasg; Anderson, Peter L.g; Kwara, Awewuraf, h
No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study

泰国变性女性中口服TAF为基础的PrEP与雌性化激素疗法之间无显著药物相互作用：iFACT-3研究

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
IF4.9
2025-05-190
OA
Hiransuthikul, Akarin; Thammajaruk, Narukjaporn; Kerr, Stephen; Janamnuaysook, Rena; Nonenoy, Siriporn; Hongchookiat, Piranun; Trichavaroj, Rapee; Tawon, Yardpiroon; Boonruang, Jakkrapatara; Teeratakulpisarn, Nipat; Cressey, Tim R.; Anderson, Peter L.

研究方向

暂未获取到该数据
L
Lane R. Bushman
H 指数:37论文数:210被引数:1.1万
J
José Castillo‐Mancilla
H 指数:27论文数:119被引数:3,060
J
Jennifer J. Kiser
H 指数:37论文数:193被引数:5,494
S
Samantha MaWhinney
H 指数:41论文数:170被引数:6,355
M
Mark A. Marzinke
H 指数:49论文数:297被引数:1.0万
R
Robert M. Grant
H 指数:100论文数:1,042被引数:7.9万
C
Craig W. Hendrix
H 指数:64论文数:368被引数:2.3万
D
David V. Glidden
H 指数:83论文数:451被引数:3.1万
Z
Zheng, JH
H 指数:0论文数:0被引数:0
M
Mary Morrow
H 指数:16论文数:41被引数:918